This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2yen

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2yen.jpg|left|200px]]
+
[[Image:2yen.png|left|200px]]
-
<!--
 
-
The line below this paragraph, containing "STRUCTURE_2yen", creates the "Structure Box" on the page.
 
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
 
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
 
-
or leave the SCENE parameter empty for the default display.
 
-
-->
 
{{STRUCTURE_2yen| PDB=2yen | SCENE= }}
{{STRUCTURE_2yen| PDB=2yen | SCENE= }}
===Solution structure of the skeletal muscle and neuronal voltage gated sodium channel antagonist mu-conotoxin CnIIIC===
===Solution structure of the skeletal muscle and neuronal voltage gated sodium channel antagonist mu-conotoxin CnIIIC===
- 
-
<!--
 
-
The line below this paragraph, {{ABSTRACT_PUBMED_22229737}}, adds the Publication Abstract to the page
 
-
(as it appears on PubMed at http://www.pubmed.gov), where 22229737 is the PubMed ID number.
 
-
-->
 
{{ABSTRACT_PUBMED_22229737}}
{{ABSTRACT_PUBMED_22229737}}

Revision as of 06:58, 4 July 2012

Image:2yen.png

Template:STRUCTURE 2yen

Solution structure of the skeletal muscle and neuronal voltage gated sodium channel antagonist mu-conotoxin CnIIIC

Template:ABSTRACT PUBMED 22229737

About this Structure

2yen is a 1 chain structure. Full experimental information is available from OCA.

Reference

  • Favreau P, Benoit E, Hocking HG, Carlier L, D'hoedt D, Leipold E, Markgraf R, Schlumberger S, Cordova MA, Gaertner H, Paolini-Bertrand M, Hartley O, Tytgat J, Heinemann SH, Bertrand D, Boelens R, Stocklin R, Molgo J. Pharmacological characterization of a novel mu-conopeptide, CnIIIC, indicates potent and preferential inhibition of sodium channel subtypes (Na(V) 1.2/1.4) and reveals unusual activity on neuronal nicotinic acetylcholine receptors. Br J Pharmacol. 2012 Jan 9. doi: 10.1111/j.1476-5381.2012.01837.x. PMID:22229737 doi:10.1111/j.1476-5381.2012.01837.x

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2yen"
Personal tools